Однонуклеотидные полиморфизмы: роль в развитии рака молочной железы и перспективы клинического применения Single nucleotide polymorphisms: the role of breast cancer development and clinical perspective

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Hereditary Breast Cancer: The Era of New Susceptibility Genes

  2013cited by this paper
• Breast cancer genes: beyond BRCA1 and BRCA2.

  2013cited by this paper
• Common breast cancer risk variants in the post-COGS era: a comprehensive review

  2013cited by this paper
• Large-scale genotyping identifies 41 new loci associated with breast cancer risk

  2013cited by this paper
• Hereditary Breast Cancer: Practical Pursuit for Clinical Translation

  2012cited by this paper
• A role for common genomic variants in the assessment of familial breast cancer.

  2012cited by this paper
• A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population

  2012cited by this paper
• Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany

  2011cited by this paper
• Performance of Common Genetic Variants in Breast-Cancer Risk Models

  2011cited by this paper
• Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies

  2011cited by this paper
• Pathology of hereditary breast cancer

  2011cited by this paper
• Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

  2010cited by this paper
• Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

  2010cited by this paper
• Association of FGFR2 gene polymorphisms with the risk of breast cancer in population of West Siberia

  2009cited by this paper
• Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

  2009cited by this paper
• Breast cancer susceptibility: current knowledge and implications for genetic counselling

  2009cited by this paper
• Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics

  2008cited by this paper
• Common breast cancer predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

  2008cited by this paper
• An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)

  2007cited by this paper
• Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk

  2007cited by this paper
• Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer

  2007cited by this paper
• Genome-wide association study identifies novel breast cancer susceptibility loci

  2007cited by this paper
• Meta-analysis of BRCA1 and BRCA2 penetrance.

  2007cited by this paper
• A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

  2007cited by this paper
• Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening

  2006cited by this paper
• Models of genetic susceptibility to breast cancer

  2006cited by this paper
• Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: An update

  2006cited by this paper
• Genome-wide association studies: theoretical and practical concerns

  2005cited by this paper
• Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

  2003cited by this paper
• A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

  2002cited by this paper
• Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer.

  2000cited by this paper
• Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.

  1999cited by this paper
• Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

  1998cited by this paper
• Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1994cited by this paper
• Supplementary Issue: Classification, Predictive Modelling, and Statistical Analysis of Cancer Data (a) Introduction – Assessing Prediction Models to Support Clinical Decisions

  year unknowncited by this paper

• No citing papers are available for this paper.